Indeed, several studies have described IAPP-autoantibodies in T2D patients; one group has reported significantly higher IAPP-autoantibody levels in T2D patients [19], while another group has identified autoantibodies which specifically recognized cytotoxic oligomers, but not monomers or fibrils, in T2D patients [20]. Here, IAPP is linked to type 2 diabetes mellitus.